Fig. 4From: Plasma Prokineticin 1, a prognostic biomarker in colorectal cancer patients with curative resection: a retrospective cohort studyPlasma PROK1 expression affected the prognosis of patients. A The Plasma PROK1-positive group showed a poorer prognosis than that of the negative group in all stages. B In stage II patients, there was no significant difference between the two groups. C In stage III patients, there was no significant difference between the two groupsBack to article page